Drug information on Tritanrix-HB (Tetanus Toxoid) from Glaxo SmithKline Pharmaceuticals Ltd.

Medical Condition(s) for which Tritanrix-HB may be prescribed

---

Mild fever, joint pain, dizziness, muscle aches, nausea, tiredness and pain/itching/swelling/redness at the injection site.

Adult: IM/SC- Primary immunization: 3 doses (0.5 mL each of tetanus toxoid adsorbed) via IM administration; give 2nd dose 4-8 weeks after 1st dose and 3rd dose 6-12 month after 2nd dose, Booster dose: 0.5 mL.

It comes as a solution for injection, to be administered by a healthcare provider into the large muscle or under the skin.

Hypersensitivity.

• Caution should be exercised in patients with history of bleeding disorders, history of Guillain-Barre syndrome, high fever after previous vaccination, immune system disorders, illness/infection, seizures, nervous system disorders, any allergy, during pregnancy and breastfeeding.

• Avoid intravenous administration.

Avoid excess dosage.

Store between 2° – 8°C. Do not freeze it.